Summit Therapeutics Rises as Lead Asset Makes Citi Its Latest Bull
Johnson & Johnson Presents New Nipocalimab Data And Real-World Research At AAN 2025 Highlighting Phase 3 Results And Commitment To People Living With Generalized Myasthenia Gravis
Bayer in Licenses Puhe BioPharma's Cancer Candidate
Marty Makary and Jay Bhattacharya Clear Senate Hurdles to Lead FDA and NIH
Reported Earlier, AstraZeneca's TAGRISSO Data From LAURA, SAVANNAH, And ORCHARD Trials Highlight Continued Survival Gains And Expanded Role in EGFR+ Lung Cancer
Gamestop, FST Corp, Merck, UPS, And Tesla: Why These 5 Stocks Are On Investors' Radars Today